Intestinal Homeostasis and Disease Dysbiosis

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".

Deadline for manuscript submissions: 28 February 2026

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece
Interests: microbiome; metagenomics; bioinformatics; drug repositioning
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Intestinal homeostasis represents the dynamic equilibrium between the gut microbiota, the intestinal epithelial barrier, the immune system, and host-derived factors, all of which collectively sustain gastrointestinal health and function. This Special Issue delves into the latest scientific advances that elucidate how this balance is maintained and the mechanisms through which it is disrupted, leading to disease. The gut microbiota functions as a crucial metabolic organ, influencing nutrient assimilation, immune maturation, and defense against pathogens. However, this intricate system is highly sensitive to external and internal perturbations, including dietary changes, antibiotic exposure, psychological stress, and genetic predisposition, all of which can reshape the microbial ecosystem.

The disruption of this equilibrium, a condition termed dysbiosis, often results in the expansion of potentially harmful microbial populations that impair host metabolism, compromise immune regulation, and the weaken epithelial barrier’s integrity. Such alterations have been implicated in a wide array of diseases. The cutting-edge studies featured in this Special Issue investigate the ecological origins of dysbiosis, its clinical correlates, and promising therapeutic interventions.

Furthermore, this collection highlights the growing importance of microbiota–drug interactions, examining how gut microbes influence drug metabolism, efficacy, and toxicity. These interactions are bidirectional: while medications can significantly alter microbial composition and function, microbial enzymes can activate, inactivate, or transform xenobiotics, with implications for pharmacokinetics and therapeutic outcomes. By dissecting the molecular, metabolic, and immunological frameworks that distinguish a healthy (eubiotic) from a dysbiotic state, the contributions in this Special Issue pave the way for innovative strategies in diagnosis, personalized therapy, and disease prevention.

Dr. Nikolas Dovrolis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • intestinal homeostasis
  • dysbiosis
  • microbiota–drug interactions
  • host–microbe interactions
  • microbiome therapeutics
  • precision medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop